Efalizumab
id:
efalizumab-321-12578926
title:
Efalizumab
text:
Efalizumab is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection. Efalizumab binds to the CD11a subunit of lymphocyte function-associated antigen 1 and acts as an immunosuppressant by inhibiting lymphocyte activation and cell migration out of blood vessels into tissues. Efalizumab was associated with fata
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Efalizumab
date created:
date modified:
2023-12-20T19:53:08Z
main entity:
{"identifier":"Q418270","url":"https://www.wikidata.org/entity/Q418270"}
image:
fields total:
13
integrity:
14